Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases.
Artusi CA, Mishra M, Latimer P, Vizcarra JA, Lopiano L, Maetzler W, Merola A, Espay AJ.
Artusi CA, et al.
Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1(Suppl 1):S53-S56. doi: 10.1016/j.parkreldis.2017.07.022. Epub 2017 Jul 26.
Parkinsonism Relat Disord. 2018.
PMID: 28760593
Free PMC article.
Review.
The ClinicalTrials.gov search yielded 42 clinical trials using TOMs, representing 2.7% of ongoing trials. Sensor-based technology accounted for over 75% of TOMs applied. ...Within the next 5 years, 83% of surveyed pharmaceutical companies engaged in neurodegenerativ …
The ClinicalTrials.gov search yielded 42 clinical trials using TOMs, representing 2.7% of ongoing trials. Sensor-based technology acc …